Evidence map›Paper›PMID 34835774›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Silver-Protein Nanocomposites as Antimicrobial Agents.

Mahmoud Sitohy, Abdul-Raouf Al-Mohammadi, Ali Osman, Seham Abdel-Shafi, Nashwa El-Gazzar, Sara Hamdi, Sameh H Ismail, Gamal Enan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Molecular characterization of ESBL-producingFrontiers in cellular and infection microbiology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Antimicrobial and cytotoxic activities of natural (Z)-13-docosenamide derived fromFrontiers in cellular and infection microbiology · 2025
    Article
  12. Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mahmoud SitohyBiochemistry Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.ORCID 0000-0001-6623-4860
Abdul-Raouf Al-MohammadiDepartment of Science, King Khalid Military Academy, P.O. Box 22140, Riyadh 11495, Saudi Arabia.
Ali OsmanBiochemistry Department, Faculty of Agriculture, Zagazig University, Zagazig 44511, Egypt.ORCID 0000-0001-7174-0207
Seham Abdel-ShafiBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-8311-7946
Nashwa El-GazzarBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-8229-9461
Sara HamdiBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Sameh H IsmailFaculty of Nanotechnology for Postgraduate, Cairo University, Zayed City 12588, Egypt.ORCID 0000-0001-8339-1673
Gamal EnanBotany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-7794-784X
Zagazig University · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of nanomaterials alone or in composites with proteins is a promising alternative to inhibit pathogenic bacteria. In this regard, this study used seed proteins from both fenugreek (

Indexed as

antibacterial activityfenugreekmung beannanocompositeseed proteinssilver nanoparticles

Identifiers

PMID34835774
PMCPMC8617916
OpenAlexW3212261824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.